Skip to main content

Table 1 NGS testing for blastocysts

From: Improved clinical outcomes of preimplantation genetic testing for aneuploidy using MALBAC-NGS compared with MDA-SNP array

Clinical data

Couples

Total

Robertsonian translocation

Reciprocal translocation

Inversion

PGS

Sex chromosome abnormality

No. of cases

157

405

40

111

92

805

Maternal age (mean ± SD)

30.2 ± 4.9

29.4 ± 4.09

30.0 ± 4.03

35.4 ± 5.35

28.7 ± 4.06

30.3 ± 4.76

No. of blastocysts biopsied

603

1825

153

395

345

3321

Euploidy

164 (27.2%)

313 (17.2%)

54 (35.3%)

130 (32.9%)

105 (30.4%)

766 (23.1%)

Numerical abnormality

264 (43.8%)

241 (13.2%)

29 (18.9%)

131 (33.2%)

95 (27.5%)

760 (22.9%)

Structural abnormality

41 (6.8%)

237 (13.0%)

22 (14.4%)

42 (10.6%)

62 (18.0%)

404 (12.2%)

Complex abnormality

134 (22.2%)

1034 (56.6%)

48 (31.4%)

92 (23.3%)

83 (24.1%)

1391 (41.8%)